Mucolytics for chronic obstructive pulmonary disease (COPD)
Examples
| acetylcysteine |
Mucomyst, Mucosil-10, Mucosil-20 |
| iodinated glycerol |
Iophen, Organidin, Par Glycerol, R-Gen |
How It Works
Mucolytics thin
mucus to make it less sticky and easier to cough up
from the lungs and airways leading to the lungs (bronchial tubes). They
are not commonly used.
Why It Is Used
In chronic
bronchitis, the lungs produce too much mucus. Because
chronic bronchitis is often present in
chronic obstructive pulmonary disease (COPD),
mucolytics may provide some relief from symptoms. However, mucolytics are not
commonly recommended for COPD treatment.1
How Well It Works
Long-term treatment with mucolytics
may provide some relief of symptoms for people with COPD. Studies indicate that
mucolytics may decrease the risk of having future
COPD exacerbations and decrease their severity.
However, there is no evidence that mucolytics improve lung volume for people
with COPD.2
Side Effects
Side effects of acetylcysteine
include:
- Sudden tightness of the airways
(bronchospasm).
- Nausea.
- Fever.
- Drowsiness.
Bronchospasm can be a serious side effect of
acetylcysteine. However, a mild stomach upset is the most likely side
effect.
Some people who use iodinated glycerol develop a rash. In
rare cases, people who use this medication for long periods of time may develop
an underactive thyroid gland (hypothyroidism).
See Drug
Reference for a full list of side effects. (Drug Reference is not available in
all systems.)
References
Citations
-
Global Initiative for Chronic Obstructive
Lung Disease (GOLD) (2005). Executive summary (updated 2005). In
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available online:
http://www.goldcopd.com/GuidelinesResources.asp?I1=2&I2=0.
-
Kerstjens H, et al. (2005). Chronic
obstructive pulmonary disease. Clinical Evidence (13):
1923-1947.
Last Updated:
May 8, 2008
Global Initiative for Chronic Obstructive
Lung Disease (GOLD) (2005). Executive summary (updated 2005). In
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available online:
http://www.goldcopd.com/GuidelinesResources.asp?I1=2&I2=0.
Kerstjens H, et al. (2005). Chronic
obstructive pulmonary disease. Clinical Evidence (13):
1923-1947.